Dawn Siegel
Part Time Faculty · Stanford Health Care
Credentials: · · ·
History
- Present
- Present
- 1997–2000
UCSF Benioff Childrens Hospital Pediatric Residency (2000) CA
Research
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference
Review · PEDIATRICS · 2013 · 389 citations
Human Mutation · 2008 · 306 citations
Consensus Statement on Diagnostic Criteria for PHACE Syndrome
PEDIATRICS · 2009 · 263 citations
61 papers
48 papers
31 papers
28 papers
21 papers
18 papers
18 papers
16 papers · 1 as a fellow
Grants
- 2019–2022
Analysis of Whole Genome Sequencing Data From an Infantile Hemangioma Syndrome Cohort
National Institute of Child Health and Human Development · R03
Contact PI · $323.3K · Medical College of Wisconsin
- 2014–2018
Pathogenesis and Natural History in a Longitudinal Hemangioma Syndrome Cohort
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $1.4M · Medical College of Wisconsin
- 2015–2017
Pediatric Dermatology Research Alliance (PeDRA) Annual Conference
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R13
PI · $60K · University of California, San Diego
- 2013–2016
Pediatric Dermatology Research Alliance Annual Conference
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R13
Contact PI · $119.6K · Medical College of Wisconsin
Clinical trials
- 2007–2022
Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)
Principal investigator · Completed
Medical College of Wisconsin
- 2026–2029
Topical Simvastatin for Treating Infantile Hemangioma
Sub-investigator · Not yet recruiting · Early phase 1
Joyce Teng